Gene: CCDC171
Official Full Name: coiled-coil domain containing 171provided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36044 | CCDC171 Knockout cell line (HeLa) | Human | CCDC171 | 1:3~1:6 | Negative | Online Inquiry |
KO36045 | CCDC171 Knockout cell line (HCT 116) | Human | CCDC171 | 1:2~1:4 | Negative | Online Inquiry |
KO36046 | CCDC171 Knockout cell line (HEK293) | Human | CCDC171 | 1:3~1:6 | Negative | Online Inquiry |
KO36047 | CCDC171 Knockout cell line (A549) | Human | CCDC171 | 1:3~1:4 | Negative | Online Inquiry |
CCDC171 Gene Knockout Cell Lines are a series of genetically engineered cell lines designed for the specific and targeted disruption of the CCDC171 gene, which encodes for coiled-coil domain-containing protein 171, implicated in various cellular processes and disease mechanisms. These knockout cell lines serve as vital tools for researchers aiming to elucidate the role of CCDC171 in biological pathways, including cellular differentiation, proliferation, and potential pathogenesis of disorders.
The primary function of CCDC171 Gene Knockout Cell Lines lies in their ability to facilitate loss-of-function studies, enabling scientists to observe the phenotypic consequences of CCDC171 disruption. By utilizing CRISPR/Cas9 gene-editing technology, the cell lines exhibit precise gene knockout, allowing for the investigation of downstream signaling pathways and interactions with other molecular components. This unique mechanism empowers researchers to conduct experiments ranging from gene expression analysis to drug response assessments, making these cell lines valuable for both basic and applied biological research.
These gene knockout cell lines hold significant scientific importance in academic and clinical research, particularly in understanding mechanisms underlying diseases such as cancer and metabolic disorders. By elucidating the functional role of CCDC171, researchers can identify potential therapeutic targets and develop novel treatment strategies. Their application spans various fields, including molecular biology, pharmacology, and genetics, making them versatile tools in the researcher’s arsenal.
Compared to alternative models, such as transient transfection or RNA interference approaches, CCDC171 Gene Knockout Cell Lines offer greater stability and reproducibility in experiments, leading to more reliable data. This stability is critical when conducting experiments that require prolonged observation and consistent genetic backgrounds, thus enhancing the validity of research findings.
Ultimately, CCDC171 Gene Knockout Cell Lines provide researchers and clinicians with insights into gene function and regulation, aiding the advancement of scientific knowledge and fostering innovation in therapeutic development. By investing in this product, users are supported by our company’s extensive expertise in genetic engineering and commitment to providing high-quality biological products designed to meet the demands of modern research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.